Marsh et al. observed a significant dose-dependent increase in DCC gene expression in testosterone-treated neural stem cells derived from human embryonic stem cells and suggested that isolated ACC may occur when DCC gene expression is below a critical level during CC development. The gene discussed is DCC; the disease is adrenal cortex carcinoma.